Become a Readings Member to make your shopping experience even easier. Sign in or sign up for free!

Become a Readings Member. Sign in or sign up for free!

Hello Readings Member! Go to the member centre to view your orders, change your details, or view your lists, or sign out.

Hello Readings Member! Go to the member centre or sign out.

Computational and Experimental Studies in Alzheimer's Disease
Hardback

Computational and Experimental Studies in Alzheimer’s Disease

$325.99
Sign in or become a Readings Member to add this title to your wishlist.

This reference book compiles the recent advances in computational and experimental modelling to screen and manage Alzheimer's disease. It covers basic etiopathology and various in vitro and in vivo strategies of disease intervention. The book discusses how computer-aided drug design approaches reduce costs and increase biological test efficiency. It reviews the screening for anti-Alzheimer drugs and biomarker analysis of disease inhibitors. The book also explores mechanistic aspects of neurodegeneration and the use of natural products as therapeutics for Alzheimer's disease.

Key features:

Elaborates on the computational modelling of protein target inhibitors as anti-Alzheimer's agents

Explains the role of phytomolecules and natural products in Alzheimer's therapy

Reviews preclinical ways to assess drugs focusing on Alzheimer's disease

Covers biomarker analysis for Alzheimer's disease

Discusses the onset and progression of Alzheimer's disease

The book is meant for professionals, researchers, and students of neuroscience, psychology, and computational neurosciences.

Read More
In Shop
Out of stock
Shipping & Delivery

$9.00 standard shipping within Australia
FREE standard shipping within Australia for orders over $100.00
Express & International shipping calculated at checkout

MORE INFO
Format
Hardback
Publisher
Taylor & Francis Ltd
Country
United Kingdom
Date
29 March 2024
Pages
190
ISBN
9781032530079

This reference book compiles the recent advances in computational and experimental modelling to screen and manage Alzheimer's disease. It covers basic etiopathology and various in vitro and in vivo strategies of disease intervention. The book discusses how computer-aided drug design approaches reduce costs and increase biological test efficiency. It reviews the screening for anti-Alzheimer drugs and biomarker analysis of disease inhibitors. The book also explores mechanistic aspects of neurodegeneration and the use of natural products as therapeutics for Alzheimer's disease.

Key features:

Elaborates on the computational modelling of protein target inhibitors as anti-Alzheimer's agents

Explains the role of phytomolecules and natural products in Alzheimer's therapy

Reviews preclinical ways to assess drugs focusing on Alzheimer's disease

Covers biomarker analysis for Alzheimer's disease

Discusses the onset and progression of Alzheimer's disease

The book is meant for professionals, researchers, and students of neuroscience, psychology, and computational neurosciences.

Read More
Format
Hardback
Publisher
Taylor & Francis Ltd
Country
United Kingdom
Date
29 March 2024
Pages
190
ISBN
9781032530079